Morgan Stanley Seres Therapeutics, Inc. Transaction History
Morgan Stanley
- $1.39 Trillion
- Q4 2024
A detailed history of Morgan Stanley transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 2,013,251 shares of MCRB stock, worth $1.53 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,013,251
Previous 802,325
150.93%
Holding current value
$1.53 Million
Previous $762,000
119.16%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding MCRB
# of Institutions
75Shares Held
41.3MCall Options Held
2.96MPut Options Held
228K-
Flagship Pioneering Inc. Cambridge, MA23.1MShares$17.6 Million5.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.87MShares$4.46 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.81MShares$1.38 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.76MShares$1.34 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.51MShares$1.15 Million0.0% of portfolio
About Seres Therapeutics, Inc.
- Ticker MCRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,072,000
- Market Cap $94.3M
- Description
- Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...